HL7 Terminology (THO)
6.1.0 - Publication
HL7 Terminology (THO)
6.1.0 - Publication
This page is part of the HL7 Terminology (v6.1.0: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Active as of 2019-12-01 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="v2-0477"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem v2-0477</b></p><a name="v2-0477"> </a><a name="hcv2-0477"> </a><a name="v2-0477-en-US"> </a><p><b>Properties</b></p><p><b>This code system defines the following properties for its concepts</b></p><table class="grid"><tr><td><b>Name</b></td><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td><td><b>Description</b></td></tr><tr><td>status</td><td>status</td><td>http://terminology.hl7.org/CodeSystem/utg-concept-properties#status</td><td>code</td><td>Status of the concept</td></tr><tr><td>deprecated</td><td>deprecated</td><td>http://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-table-deprecated</td><td>code</td><td>Version of HL7 in which the code was deprecated</td></tr><tr><td>V2 Concept Comment</td><td>v2-concComment</td><td>http://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-concComment</td><td>string</td><td>V2 Concept Comment</td></tr><tr><td>V2 Concept Comment As Published</td><td>v2-concCommentAsPub</td><td>http://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-concCommentAsPub</td><td>string</td><td>V2 Concept Comment As Published</td></tr></table><p><b>Concepts</b></p><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/v2-0477</code> defines the following codes in a Is-A hierarchy:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>V2 Concept Comment</b></td><td><b>V2 Concept Comment As Published</b></td></tr><tr><td style="white-space:nowrap">I<a name="v2-0477-I"> </a></td><td>Schedule I</td><td>Schedule I</td><td>Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.</td><td>Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.</td></tr><tr><td style="white-space:nowrap">II<a name="v2-0477-II"> </a></td><td>Schedule II</td><td>Schedule II</td><td>Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.</td><td>Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.</td></tr><tr><td style="white-space:nowrap">III<a name="v2-0477-III"> </a></td><td>Schedule III</td><td>Schedule III</td><td>Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.</td><td>Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.</td></tr><tr><td style="white-space:nowrap">IV<a name="v2-0477-IV"> </a></td><td>Schedule IV</td><td>Schedule IV</td><td>Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.</td><td>Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.</td></tr><tr><td style="white-space:nowrap">V<a name="v2-0477-V"> </a></td><td>Schedule V</td><td>Schedule V</td><td>Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.</td><td>Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.</td></tr><tr><td style="white-space:nowrap">VI<a name="v2-0477-VI"> </a></td><td>Schedule VI</td><td>Schedule VI</td><td>State defined</td><td>State defined</td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="oo"/>
</extension>
<url value="http://terminology.hl7.org/CodeSystem/v2-0477"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.18.304"/>
</identifier>
<version value="2.0.0"/>
<name value="ControlledSubstanceSchedule"/>
<title value="controlledSubstanceSchedule"/>
<status value="active"/>
<experimental value="false"/>
<date value="2019-12-01"/>
<publisher value="Health Level Seven International"/>
<contact>
<telecom>
<system value="url"/>
<value value="http://hl7.org"/>
</telecom>
<telecom>
<system value="email"/>
<value value="hq@HL7.org"/>
</telecom>
</contact>
<description
value="Code system of concepts specifying the class of the drug or other substance if its usage is controlled by legislation. In the USA, such legislation includes the federal Controlled Substance Act (CSA) or a State Uniform Controlled Substance Act. Other countries should create their own versions of this table. Used in HL7 Version 2.x messaging in the RXE segment. The name of the table is taken from the Pharmacy Law Digest July 1988."/>
<purpose
value="Underlying Master Code System for V2 table 0477 (Controlled Substance Schedule)"/>
<copyright
value="This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html"/>
<caseSensitive value="true"/>
<valueSet value="http://terminology.hl7.org/ValueSet/v2-0477"/>
<hierarchyMeaning value="is-a"/>
<compositional value="false"/>
<versionNeeded value="false"/>
<content value="complete"/>
<property>
<code value="status"/>
<uri
value="http://terminology.hl7.org/CodeSystem/utg-concept-properties#status"/>
<description value="Status of the concept"/>
<type value="code"/>
</property>
<property>
<code value="deprecated"/>
<uri
value="http://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-table-deprecated"/>
<description value="Version of HL7 in which the code was deprecated"/>
<type value="code"/>
</property>
<property>
<code value="v2-concComment"/>
<uri
value="http://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-concComment"/>
<description value="V2 Concept Comment"/>
<type value="string"/>
</property>
<property>
<code value="v2-concCommentAsPub"/>
<uri
value="http://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-concCommentAsPub"/>
<description value="V2 Concept Comment As Published"/>
<type value="string"/>
</property>
<concept id="4888">
<code value="I"/>
<display value="Schedule I"/>
<definition value="Schedule I"/>
<property>
<code value="v2-concComment"/>
<valueString
value="Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision."/>
</property>
<property>
<code value="v2-concCommentAsPub"/>
<valueString
value="Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision."/>
</property>
<property>
<code value="status"/>
<valueCode value="A"/>
</property>
</concept>
<concept id="4889">
<code value="II"/>
<display value="Schedule II"/>
<definition value="Schedule II"/>
<property>
<code value="v2-concComment"/>
<valueString
value="Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability."/>
</property>
<property>
<code value="v2-concCommentAsPub"/>
<valueString
value="Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability."/>
</property>
<property>
<code value="status"/>
<valueCode value="A"/>
</property>
</concept>
<concept id="4890">
<code value="III"/>
<display value="Schedule III"/>
<definition value="Schedule III"/>
<property>
<code value="v2-concComment"/>
<valueString
value="Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States."/>
</property>
<property>
<code value="v2-concCommentAsPub"/>
<valueString
value="Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States."/>
</property>
<property>
<code value="status"/>
<valueCode value="A"/>
</property>
</concept>
<concept id="4891">
<code value="IV"/>
<display value="Schedule IV"/>
<definition value="Schedule IV"/>
<property>
<code value="v2-concComment"/>
<valueString
value="Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States."/>
</property>
<property>
<code value="v2-concCommentAsPub"/>
<valueString
value="Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States."/>
</property>
<property>
<code value="status"/>
<valueCode value="A"/>
</property>
</concept>
<concept id="4892">
<code value="V"/>
<display value="Schedule V"/>
<definition value="Schedule V"/>
<property>
<code value="v2-concComment"/>
<valueString
value="Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States."/>
</property>
<property>
<code value="v2-concCommentAsPub"/>
<valueString
value="Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States."/>
</property>
<property>
<code value="status"/>
<valueCode value="A"/>
</property>
</concept>
<concept id="4893">
<code value="VI"/>
<display value="Schedule VI"/>
<definition value="Schedule VI"/>
<property>
<code value="v2-concComment"/>
<valueString value="State defined"/>
</property>
<property>
<code value="v2-concCommentAsPub"/>
<valueString value="State defined"/>
</property>
<property>
<code value="status"/>
<valueCode value="A"/>
</property>
</concept>
</CodeSystem>
IG © 2020+ HL7 International - Vocabulary Work Group. Package hl7.terminology#6.1.0 based on FHIR 5.0.0. Generated 2024-11-17
Links: Table of Contents |
QA Report
| Version History 
|
|
Propose a change